Cargando…
Diagnostic laboratory testing for Charcot Marie Tooth disease (CMT): the spectrum of gene defects in Norwegian patients with CMT and its implications for future genetic test strategies
BACKGROUND: Current genetic test algorithms for Charcot Marie Tooth (CMT) disease are based on family details and comprehensive clinical and neurophysiological data gathered under ideal conditions for clinical assessment. However, in a diagnostic laboratory setting relying on external test requisiti...
Autores principales: | Østern, Rune, Fagerheim, Toril, Hjellnes, Helene, Nygård, Bjørn, Mellgren, Svein I, Nilssen, Øivind |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849068/ https://www.ncbi.nlm.nih.gov/pubmed/24053775 http://dx.doi.org/10.1186/1471-2350-14-94 |
Ejemplares similares
-
Segregation analysis in families with Charcot-Marie-Tooth disease allows reclassification of putative disease causing mutations
por: Østern, Rune, et al.
Publicado: (2014) -
Ascorbic acid in Charcot–Marie–Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial
por: Pareyson, Davide, et al.
Publicado: (2011) -
Accelerate Clinical Trials in Charcot-Marie-Tooth Disease (ACT-CMT): A Protocol to Address Clinical Trial Readiness in CMT1A
por: Eichinger, Katy, et al.
Publicado: (2022) -
MFN2 point mutations occur in 3.4% of Charcot-Marie-Tooth families. An investigation of 232 Norwegian CMT families
por: Braathen, Geir J, et al.
Publicado: (2010) -
Genetics of Charcot-Marie-Tooth (CMT) Disease within the Frame of the Human Genome Project Success
por: Timmerman, Vincent, et al.
Publicado: (2014)